Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor1α promoter
- 1 October 2001
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (20) , 1539-1546
- https://doi.org/10.1038/sj.gt.3301561
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 31 references indexed in Scilit:
- TNFα and IFNγ Induced by Innate Anti-adenoviral Immune Responses Inhibit Adenovirus-Mediated Transgene ExpressionMolecular Therapy, 2001
- Linear DNAs Concatemerize in Vivo and Result in Sustained Transgene Expression in Mouse LiverMolecular Therapy, 2001
- Reduced Inflammatory Response to Plasmid DNA Vectors by Elimination and Inhibition of Immunostimulatory CpG MotifsMolecular Therapy, 2000
- Increased Duration of Transgene Expression in the Lung with Plasmid DNA Vectors Harboring Adenovirus E4 Open Reading Frame 3Human Gene Therapy, 1999
- Effects of altering dosing on cationic liposome-mediated gene transfer to the respiratory epitheliumGene Therapy, 1999
- Optimization of Plasmid Vectors for High-Level Expression in Lung Epithelial CellsHuman Gene Therapy, 1997
- Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.The Journal of cell biology, 1995
- A novel cationic liposome reagent for efficient transfection of mammalian cellsBiochemical and Biophysical Research Communications, 1991
- Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomesCell, 1986
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977